Nascent Biotech is the home of the natural human antibody cancer product Pritimumab, which has been shown to fight rare forms of cancer successfully.
Investors 1
| Date | Name | Website |
| - | TRITON FUN... | tritonfund... |
Mentions in press and media 1
| Date | Title | Description |
| 12.04.2022 | Nascent Biotech and BioTools Partner in the Fight Against Cancer Using ROA to Define the Higher Order Structure of PTB, a Unique Monoclonal Antibody | VERO BEACH, FL / ACCESSWIRE / April 12, 2022 / Nascent Biotech, developer of Pritumumab (PTB), a monoclonal antibody showing promise in the treatment of brain cancer, has partnered with BioTools, Inc to clearly define PTB's higher order mol... |